Prot #1378-0006: EASi-KIDNEY: Studies of Heart & Kidney Protection with BI 690517 in Combination with Empagliflozin: A Multicenter, International, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Aldosterone Synthase Inhibitor BI 690517

Project: Research project

Project Details

StatusActive
Effective start/end date10/7/2410/7/27

Funding

  • Duke University (Prot #1378-0006 // Prot #1378-0006)
  • Boehringer Ingelheim Pharmaceuticals, Inc. (Prot #1378-0006 // Prot #1378-0006)